Резултати
eNauka >
Results >
P40 HRD testing doubled the number of ovarian cancer patients eligible for PARP inhibitor therapy
| Title: | P40 HRD testing doubled the number of ovarian cancer patients eligible for PARP inhibitor therapy | Authors: | Živić, Katarina |
Issue Date: | 2025 | Publication: | The 1st Regional SDIR-HDIR-MOKAD Congress. Proceedings Book. | ISSN: | ISSNe 3009-383X![]() Search Idenfier |
Publisher: | SDIR | Type: | Conference Paper | Collation: | str. 118-119 P40 | URI: | https://enauka.gov.rs/handle/123456789/1003872 | URL: | https://www.sdir.ac.rs/pdf/Abstract%20Book%20-%20SDIR-7.pdf https://www.sdir.ac.rs/about-sdir-7/ |
Metadata source: | (Preuzeto iz ORCID-a) Živić, Katarina | M-category: | Mp. category will be shown later |
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.
